Novartis (NVS)

Add to Watchlists
Create an Alert
81.48 -0.55  -0.67% NYSE Sep 23, 20:00 Delayed 2m USD

Novartis Enterprise Value:

220.46B for Sept. 23, 2016
View 4,000+ financial data types
Browse...
View Full Chart

Novartis Enterprise Value Chart

Export Data
Save Image

Novartis Historical Enterprise Value Data

View and export this data going back to 1995. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 23, 2016 220.46B
Sept. 22, 2016 221.77B
Sept. 21, 2016 220.56B
Sept. 20, 2016 219.46B
Sept. 19, 2016 216.80B
Sept. 16, 2016 215.37B
Sept. 15, 2016 216.65B
Sept. 14, 2016 214.82B
Sept. 13, 2016 214.84B
Sept. 12, 2016 217.61B
Sept. 9, 2016 213.73B
Sept. 8, 2016 217.54B
Sept. 7, 2016 217.80B
Sept. 6, 2016 217.30B
Sept. 2, 2016 215.46B
Sept. 1, 2016 212.82B
Aug. 31, 2016 214.01B
Aug. 30, 2016 215.37B
Aug. 29, 2016 216.08B
Aug. 26, 2016 215.30B
Aug. 25, 2016 215.87B
Aug. 24, 2016 217.65B
Aug. 23, 2016 220.18B
Aug. 22, 2016 220.08B
Aug. 19, 2016 220.13B
   
Aug. 18, 2016 221.56B
Aug. 17, 2016 221.18B
Aug. 16, 2016 221.15B
Aug. 15, 2016 222.51B
Aug. 12, 2016 221.89B
Aug. 11, 2016 223.61B
Aug. 10, 2016 222.37B
Aug. 9, 2016 223.23B
Aug. 8, 2016 222.37B
Aug. 5, 2016 224.37B
Aug. 4, 2016 223.85B
Aug. 3, 2016 222.65B
Aug. 2, 2016 223.99B
Aug. 1, 2016 224.25B
July 29, 2016 224.70B
July 28, 2016 221.89B
July 27, 2016 223.82B
July 26, 2016 224.13B
July 25, 2016 225.18B
July 22, 2016 225.30B
July 21, 2016 223.46B
July 20, 2016 224.13B
July 19, 2016 220.58B
July 18, 2016 221.80B
July 15, 2016 220.77B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Advertisement

NVS Enterprise Value Benchmarks

Companies
AstraZeneca 100.74B
GlaxoSmithKline 130.77B
Johnson & Johnson 308.71B

NVS Enterprise Value Range, Past 5 Years

Minimum 143.55B Mar 06 2012
Maximum 273.77B Jul 20 2015
Average 204.88B

NVS Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("NVS", "enterprise_value")
  • Last 5 data points: =YCS("NVS", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.